Table 4.
KRIs of Pharmaceutical Company
| NO | Formula | Mean | SD | Reference |
|---|---|---|---|---|
| 1 | Value of company`s IT investment during last 6 months / Value of company`s IT investment during current 6 months | 3.78 | 1.2 | (40) |
| 2 | Value of company sale to pharmacies during 3 months / Total value of sales to pharmacies during last 3 months | 5 | 0 | (23) |
| 3 | Value of net profit during last 3 months / Value of investment during last 3 months | 5 | 0 | (41) |
| 4 | Current Ratio: Current assets / Current liabilities | 5 | 0 | (42) |
| 5 | Current credit during last month / Total purchasing during last month | 4.60 | 0.18 | (42) |
| 6 | Total cost reduction of raw materials by changing products formulation / Total cost reduction of raw materials | 4.12 | 0.23 | (23) |
| 7 | Value of accounting profit during last month / Total value of company sales during last month | 4.12 | 0.34 | (43, 44) |
| 8 | Value of exported pharma products during last three months /T otal value of pharma products exported during 3 months | 4 | 0.53 | (30) |
| 9 | Value of sales during last 3 month / Value of inventories at stock during last 3 month | 4 | 0.41 | (27, 37) |
| 10 | Current debt / Sales (value) | 3.90 | 0.46 | (42) |
| 11 | Value of new products’ profit for 3 months / Value of total products profit | 3.67 | 0.35 | (44) |
| 12 | Total value of wasted materials for 1 month / Total value of materials for 1 month | 3.5 | 0.32 | (27, 29) |
| 13 | Value of company sale at internal pharma market during last 3 months / Total sale at internal pharma market during last 3 month s | 3 | 0.34 | (30) |
| 14 | Value of canceled invoice to customer during last 3 months / Value of company total sale during 3 months | 2.5 | 0.97 | (38) |
Note: SD = Standard Deviation